Literature DB >> 3488142

Warfarin administration increases uric acid concentrations in plasma.

R K Menon, D P Mikhailidis, J L Bell, P B Kernoff, P Dandona.   

Abstract

The effect of warfarin administration on plasma uric acid was investigated. A representative sample of patients on long-term warfarin treatment had a significantly higher concentration of uric acid in plasma than did age-matched patients with comparable plasma urea concentrations who were not taking warfarin. In women, this association was observed only in patients with normal values for plasma urea, not in those with high values. In contrast, in men this association was present in both groups (normal and high plasma urea). In a longitudinal study involving patients, their plasma uric acid significantly increased after warfarin administration. There was no significant change in the renal clearance of uric acid after a single dose of warfarin in normal, healthy volunteers; this contrasts with the increase observed with other coumarin anticoagulants. Our findings suggest that the increase in plasma uric acid noted with warfarin administration is probably due to an increase in uric acid production and may predispose to gout those patients who are on long-term therapy with warfarin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488142

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  The chicken or the egg story: which came first, epigastric hernia in a patient with huge urinary bladder stone.

Authors:  Abdul Majid Wani; Waleed Mohd Hussain; Mohamad Ibrahim Fatani; Sadeya Hanif Raja; Khaled Shawkat Ali; Ashraf Basraheel; Mubeena Akhtar; Mazen G Bafaraj
Journal:  BMJ Case Rep       Date:  2009-12-03

2.  Lower serum uric acid level strongly predict short-term poor functional outcome in acute stroke with normoglycaemia: a cohort study in China.

Authors:  Shuolin Wu; Yuesong Pan; Ning Zhang; Wang Yong Jun; Chunxue Wang
Journal:  BMC Neurol       Date:  2017-02-01       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.